82 related articles for article (PubMed ID: 15358478)
1. A patient with granulocyte-colony stimulating factor-producing endometrial cancer who responded to high-dose cisplatin, cyclophosphamide and adriamycin.
Hada T; Mikami M; Kuwabara Y; Tanaka K; Ishikawa M; Komiyama S; Hirose T
Eur J Obstet Gynecol Reprod Biol; 2004 Oct; 116(2):242-3. PubMed ID: 15358478
[No Abstract] [Full Text] [Related]
2. Patient-reported peripheral neuropathy of doxorubicin and cisplatin with and without paclitaxel in the treatment of advanced endometrial cancer: Results from GOG 184.
Cella D; Huang H; Homesley HD; Montag A; Salani R; De Geest K; Lee R; Spirtos NM
Gynecol Oncol; 2010 Dec; 119(3):538-42. PubMed ID: 20863554
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel/carboplatin versus cyclophosphamide/adriamycin/cisplatin as postoperative adjuvant chemotherapy for advanced endometrial adenocarcinoma.
Hidaka T; Nakamura T; Shima T; Yuki H; Saito S
J Obstet Gynaecol Res; 2006 Jun; 32(3):330-7. PubMed ID: 16764625
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
Ohara N; Teramoto K; Murao S
J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
[No Abstract] [Full Text] [Related]
5. Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: a Japanese Gynecologic Oncology Group study.
Susumu N; Sagae S; Udagawa Y; Niwa K; Kuramoto H; Satoh S; Kudo R;
Gynecol Oncol; 2008 Jan; 108(1):226-33. PubMed ID: 17996926
[TBL] [Abstract][Full Text] [Related]
6. Grave outcome of granulocyte colony-stimulating factor-producing endometrial cancer: a case report and literature review.
Yamamoto K; Mabuchi S; Yamasaki M; Yoshimura M; Murata Y
J Obstet Gynaecol Res; 2013 May; 39(5):1107-10. PubMed ID: 23279043
[TBL] [Abstract][Full Text] [Related]
7. New aspects of adjuvant therapy in endometrial cancer: current standards and future directions.
Sehouli J; Koensgen D; Oskay-Ozcelik G; Mustea A
Crit Rev Oncol Hematol; 2008 Sep; 67(3):204-12. PubMed ID: 18407513
[TBL] [Abstract][Full Text] [Related]
8. [Recent outline of chemotherapy for uterine endometrial cancer].
Watanabe Y; Hoshiai H
Nihon Rinsho; 2004 Oct; 62 Suppl 10():346-50. PubMed ID: 15535265
[No Abstract] [Full Text] [Related]
9. Effectiveness of postoperative chemotherapy for para-aortic lymph node metastasis of endometrial cancer.
Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
Gynecol Oncol; 2006 Aug; 102(2):214-7. PubMed ID: 16457876
[TBL] [Abstract][Full Text] [Related]
10. [A feasibility study of doxorubicin/cisplatin (AP) for postoperative chemotherapy in patients with advanced endometrial cancer].
Nishio S; Katsumata N; Tanabe H; Matsumoto K; Yonemori K; Kouno T; Shimizu C; Ando M; Fujiwara Y
Gan To Kagaku Ryoho; 2006 Nov; 33(11):1589-93. PubMed ID: 17108724
[TBL] [Abstract][Full Text] [Related]
11. Prospective, randomized comparison of high-dose chemotherapy with stem-cell support versus intermediate-dose chemotherapy after surgery and adjuvant chemotherapy in women with high-risk primary breast cancer: a report of CALGB 9082, SWOG 9114, and NCIC MA-13.
Peters WP; Rosner GL; Vredenburgh JJ; Shpall EJ; Crump M; Richardson PG; Schuster MW; Marks LB; Cirrincione C; Norton L; Henderson IC; Schilsky RL; Hurd DD
J Clin Oncol; 2005 Apr; 23(10):2191-200. PubMed ID: 15767638
[TBL] [Abstract][Full Text] [Related]
12. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
[TBL] [Abstract][Full Text] [Related]
13. Feasibility study of concurrent weekly cisplatin and whole abdominopelvic irradiation followed by doxorubicin/cisplatin chemotherapy for advanced stage endometrial carcinoma: a Gynecologic Oncology Group trial.
Soper JT; Reisinger SA; Ashbury R; Jones E; Clarke-Pearson DL
Gynecol Oncol; 2004 Oct; 95(1):95-100. PubMed ID: 15385116
[TBL] [Abstract][Full Text] [Related]
14. Human immunodeficiency virus-associated diffuse non-Hodgkin's lymphoma in Venezuelan patients: treatment with full-dose cyclophosphamide-doxorubicin-vincristine-prednisone without routine use of granulocyte-colony stimulating factor.
Hernàndez DE; Hernàndez AE
Eur J Cancer Care (Engl); 2006 Dec; 15(5):493-6. PubMed ID: 17177909
[TBL] [Abstract][Full Text] [Related]
15. Prevention of chemotherapy-induced febrile neutropenia by prophylactic antibiotics plus or minus granulocyte colony-stimulating factor in small-cell lung cancer: a Dutch Randomized Phase III Study.
Timmer-Bonte JN; de Boo TM; Smit HJ; Biesma B; Wilschut FA; Cheragwandi SA; Termeer A; Hensing CA; Akkermans J; Adang EM; Bootsma GP; Tjan-Heijnen VC
J Clin Oncol; 2005 Nov; 23(31):7974-84. PubMed ID: 16258098
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer-producing granulocyte colony-stimulating factor.
Matsuoka Y; Arai G; Okada Y; Aida J
Urol Int; 2009; 82(1):113-5. PubMed ID: 19172109
[TBL] [Abstract][Full Text] [Related]
17. [Importance of dose intensity in chemotherapy--lessons from adjuvant chemotherapy for early breast cancer].
Tamura K
Rinsho Ketsueki; 2009 Apr; 50(4):276-81. PubMed ID: 19404020
[No Abstract] [Full Text] [Related]
18. The relationship between histology and outcome in advanced and recurrent endometrial cancer patients participating in first-line chemotherapy trials: a Gynecologic Oncology Group study.
McMeekin DS; Filiaci VL; Thigpen JT; Gallion HH; Fleming GF; Rodgers WH;
Gynecol Oncol; 2007 Jul; 106(1):16-22. PubMed ID: 17574073
[TBL] [Abstract][Full Text] [Related]
19. CHOP versus CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma.
Alliot C
J Clin Oncol; 2005 Jul; 23(21):4797-9; author reply 4799-800. PubMed ID: 16034060
[No Abstract] [Full Text] [Related]
20. Reduction from seven to five cycles of intensive induction chemotherapy in children with high-risk neuroblastoma.
Kushner BH; Kramer K; LaQuaglia MP; Modak S; Yataghene K; Cheung NK
J Clin Oncol; 2004 Dec; 22(24):4888-92. PubMed ID: 15611504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
